IFM Investors Pty Ltd Sells 919 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

IFM Investors Pty Ltd lowered its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.1% in the third quarter, Holdings Channel.com reports. The firm owned 43,162 shares of the medical device company’s stock after selling 919 shares during the period. IFM Investors Pty Ltd’s holdings in Cooper Companies were worth $4,762,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Wellington Management Group LLP grew its holdings in Cooper Companies by 34.8% during the fourth quarter. Wellington Management Group LLP now owns 8,189 shares of the medical device company’s stock worth $3,099,000 after buying an additional 2,116 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of Cooper Companies by 319.3% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 6,613 shares of the medical device company’s stock worth $671,000 after acquiring an additional 5,036 shares in the last quarter. SteelPeak Wealth LLC purchased a new stake in shares of Cooper Companies in the first quarter valued at about $237,000. LVW Advisors LLC lifted its position in shares of Cooper Companies by 293.8% during the first quarter. LVW Advisors LLC now owns 8,647 shares of the medical device company’s stock valued at $877,000 after purchasing an additional 6,451 shares in the last quarter. Finally, Mirador Capital Partners LP boosted its holdings in Cooper Companies by 305.4% during the first quarter. Mirador Capital Partners LP now owns 15,416 shares of the medical device company’s stock worth $1,564,000 after purchasing an additional 11,613 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Insider Activity

In other news, COO Daniel G. Mcbride sold 114,992 shares of the company’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at $4,714,534.08. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the company’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the transaction, the chief operating officer now owns 44,696 shares in the company, valued at $4,714,534.08. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is owned by corporate insiders.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $107.82 on Friday. The firm has a market capitalization of $21.47 billion, a PE ratio of 60.07, a P/E/G ratio of 2.53 and a beta of 0.98. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The company has a 50-day moving average price of $105.73 and a two-hundred day moving average price of $96.71. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. During the same period last year, the firm earned $0.84 EPS. Cooper Companies’s revenue for the quarter was up 7.8% on a year-over-year basis. Equities analysts forecast that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Morgan Stanley increased their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 10th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Robert W. Baird boosted their price objective on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 target price (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Finally, Wells Fargo & Company boosted their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $115.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.